搜尋結果
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg· 3 日前... delayed a breast- and lung-cancer trial of an experimental treatment that BioNTech ... ...
US FDA puts partial clinical hold on BioNTech's early-stage study of cancer drug
Reuters· 3 日前, opens new tab on Monday the U.S. Food and Drug Administration has placed a partial clinical ...
FDA asks COVID vaccine makers to target KP.2 strain with updated shots
Reuters· 5 日前The U.S. Food and Drug Administration recommended COVID-19 vaccine makers target the KP.2 ...
Moderna stock is lone omen of bird flu pandemic
Reuters· 2 日前The recent rise of Moderna’s stock tells a grim tale. The $56 billion company which pioneered a ...
Kansas accuses Pfizer of misleading public about COVID vaccine in lawsuit
Reuters· 2 日前, opens new tab filed in the District Court of Thomas County, the state said the New York-based drugmaker's alleged false ...